Yun Mo
8Patents
2h-index
16Co-inventors
44Inventor score
Filing activity: Aug 14, 2009 → Feb 8, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8748573B2 | Formulations comprising linaclotide | Physics | 5 | Active |
| US8802628B2 | Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration | Physics | 4 | Active |
| US10369142B2 | Combination dosage form of a mu opioid receptor antagonist and an opioid agent | Human Necessities | 1 | Active |
| US10702576B2 | Stable formulations of linaclotide | Human Necessities | 0 | Active |
| US11452723B2 | Combination dosage form of a mu opioid receptor antagonist and an opioid agent | Human Necessities | 0 | Active |
| US10675325B2 | Stable formulations of linaclotide | Human Necessities | 0 | Active |
| US10946009B2 | Combination dosage form of a mu opioid receptor antagonist and an opioid agent | Human Necessities | 0 | Active |
| US9283261B2 | Linaclotide compositions | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.